<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://www.clinicalobserver.com/biotech/sac-tmt-meets-os-endpoint-in-phase-3-gastroesophageal-cancer-trial</loc><news:news><news:publication><news:name>Clinical Observer</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T16:26:50.349Z</news:publication_date><news:title>Sac-TMT meets OS endpoint in Phase 3 gastroesophageal cancer trial</news:title></news:news></url><url><loc>https://www.clinicalobserver.com/public-health/virginia-reports-first-measles-associated-death-of-2026-in-young-child</loc><news:news><news:publication><news:name>Clinical Observer</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T13:43:04.466Z</news:publication_date><news:title>Virginia reports first measles-associated death of 2026 in young child</news:title></news:news></url><url><loc>https://www.clinicalobserver.com/policy/fda-rejects-capricors-deramiocel-for-duchenne-muscular-dystrophy</loc><news:news><news:publication><news:name>Clinical Observer</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T01:02:30.743Z</news:publication_date><news:title>FDA rejects Capricor's deramiocel for Duchenne muscular dystrophy</news:title></news:news></url><url><loc>https://www.clinicalobserver.com/policy/cms-proposes-2028-medicare-advantage-rule-with-food-benefit-standard-and</loc><news:news><news:publication><news:name>Clinical Observer</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20T23:28:48.221Z</news:publication_date><news:title>CMS proposes 2028 Medicare Advantage rule with food benefit standard and mandatory model</news:title></news:news></url><url><loc>https://www.clinicalobserver.com/policy/cms-proposes-medicare-advantage-rule-to-expand-food-and-plan-competition</loc><news:news><news:publication><news:name>Clinical Observer</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20T22:38:02.960Z</news:publication_date><news:title>CMS proposes Medicare Advantage rule to expand food and plan competition</news:title></news:news></url><url><loc>https://www.clinicalobserver.com/biotech/pfizer-licenses-starna-in-vivo-car-t-programs-in-2-6bn-deal</loc><news:news><news:publication><news:name>Clinical Observer</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20T20:33:04.913Z</news:publication_date><news:title>Pfizer licenses Starna in vivo CAR-T programs in $2.6bn deal</news:title></news:news></url><url><loc>https://www.clinicalobserver.com/research/daraxonrasib-cuts-death-risk-60-in-phase-3-pancreatic-cancer-trial</loc><news:news><news:publication><news:name>Clinical Observer</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20T14:10:50.371Z</news:publication_date><news:title>Daraxonrasib cuts death risk 60% in Phase 3 pancreatic cancer trial</news:title></news:news></url><url><loc>https://www.clinicalobserver.com/policy/drugmakers-say-they-will-not-start-new-trials-at-china-military-hospitals</loc><news:news><news:publication><news:name>Clinical Observer</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20T00:17:24.218Z</news:publication_date><news:title>Drugmakers say they will not start new trials at China military hospitals</news:title></news:news></url></urlset>